What is the Intromedic Co., Ltd. stock price forecast?

Intromedic Co., Ltd. is currently trading at ₩150. View real-time AI analysis on Alpha Lenz.

What is Intromedic Co., Ltd. insider trading activity?

View the latest insider trading data for Intromedic Co., Ltd. on Alpha Lenz.

What is Intromedic Co., Ltd.'s P/E ratio?

Intromedic Co., Ltd.'s P/E ratio is -0.9.

Intromedic Co., Ltd.

KRX · 150840

₩150-20(-11.76%)Market closed

Ask about Intromedic Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Intromedic Co., Ltd. trades at a P/E of -0.9 (undervalued) with modest ROE of -101.9%.”

Ask for details →

Company Overview

Intromedic Co., Ltd. is a prominent company specializing in advanced medical technology solutions. Its primary focus is on the development and manufacturing of minimally invasive medical devices, which are crucial for modern healthcare systems. The company's flagship product includes capsule endoscopy solutions, which facilitate non-invasive internal diagnostics, significantly impacting the fields of gastroenterology and internal medicine. By emphasizing innovation and patient-friendly technologies, Intromedic Co., Ltd. plays a vital role in enhancing diagnostic capabilities and patient care quality. Headquartered in South Korea, the company leverages cutting-edge research to provide effective solutions in medical diagnostics, catering to healthcare providers globally and contributing significantly to medical industry advancements.

CEO조용석(단독대표)

Websitehttps://www.intromedic.com

SectorHealthcare

IndustryMedical Devices

Employees62

Company Statistics

FY 2024

Profile

₩6,449,685,150Market Cap

₩10,383,299,540Revenue

43.00MShares Out

62Employees

Margins

65.76%Gross

-2.69%EBITDA

-13.91%Operating

-54.56%Pre-Tax

-67.12%Net

Valuation

-0.90P/E

1.07P/B

0.60EV/Sales

-25.70EV/EBITDA

-6.74P/FCF

Growth (CAGR)

9.68%Rev 3Yr

3.28%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-49.54%ROA

-101.85%ROE

-36.10%ROIC

Financial Health

₩1,413,718,260Cash & Cash Equivalents

₩3,356,264,690Net Debt

83.42%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Intromedic Co., Ltd. trades at a P/E of -0.9 (undervalued) with modest ROE of -101.9%.”

Ask for details →

Frequently Asked Questions

Intromedic Co., Ltd. (ticker: 150840) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 62 employees. Market cap is $6.4B.

The current price is ₩150 with a P/E ratio of -0.9x and P/B of 1.07x.

ROE is -101.85% and operating margin is -13.91%. Annual revenue is $10.4B.